Riskpilot← Back to searchSign inGet full accessEtac AB
ABActiveOrg 5563249746Färögatan 33Wholesale of pharmaceutical and medical goods · NACE 4646Est. 198880 employees
Revenue 2024
SEK 956M
+17% vs 2023
EBITDA margin
0.5%
+107% vs 2023
Equity ratio
30.5%
Financial strength
Net profit 2024
SEK 153,4M
+122% vs 2023
| Revenue | SEK 956M | +17% |
| EBITDA | SEK 4,9M | +107% |
| Net profit | SEK 153,4M | +122% |
| Total assets | SEK 6,3B | +21% |
| Equity | SEK 1,9B | +9% |
| Employees | 80 | — |
Legal name
Etac AB
Org number
5563249746
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 juni 1988
Share capital
SEK 1 000 000
Employees
80 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Larssen, Nora i förening med en av Castagna, Peter John Helbo, Torben Leeflang, Paul Lesjak, Mark-Philipp Mailind, Jesper Reuvers, Daniel Lee Seretis, Simon Georg Mattias Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall självt eller genom hel- eller delägda bolag, utveckla, tillverka och sälja handikapphjälpmedel och likartade sjukvårds- och hjälpmedelsprodukter samt därmed jämte tillhandahålla underhållsservice och reparationer av handikapphjälpmedel och likartade sjukvårds- och hjälpmedelsprodukter. Bolaget skall även äga, utveckla, förvalta och upplåta immateriella rättigheter såsom varumärken, patent och mönsterskydd. Bolaget skall dessutom äga och förvalta aktier i dotterbolag, intresseföretag jämte andra värdepapper. Bolaget skall vidare tillhandahålla koncerngemensamma funktioner såsom IT-tjänster, affärsutveckling, administrativa tjänster samt kunna bedriva annan med ovanstående förenlig verksamhet.
Address
Färögatan 33
Phone
+4686334700
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 443 812 | 479 608 | 521 447 | 614 435 | 722 782 | 819 890 | 956 028 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −10 735 | 14 874 | 18 217 | 37 462 | −13 303 | −17 119 | −18 548 | −8 796 | −68 024 | 4 878 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | −10 735 | 14 874 | 18 217 | 37 462 | −13 303 | −17 119 | −18 548 | −8 796 | −68 024 | 4 878 |
| Net financials | 25 745 | 94 916 | 116 134 | 32 751 | 170 620 | −263 417 | 93 724 | −330 314 | 105 799 | −88 066 |
| Profit before tax | 15 876 | 65 886 | 135 350 | 17 516 | 119 706 | 29 421 | 300 247 | 96 071 | 68 186 | 173 154 |
| Tax | 5 837 | −1 335 | −1 037 | −3 599 | 4 077 | 847 | −5 533 | −4 599 | 1 036 | −19 713 |
| Net profit | 21 713 | 64 551 | 134 313 | 13 917 | 123 783 | 30 268 | 294 714 | 91 472 | 69 222 | 153 441 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 014 568 | 1 050 430 | 1 173 596 | 1 165 295 | 3 609 058 | 3 582 798 | 4 767 169 | 5 285 424 | 5 219 681 | 6 311 358 |
| Equity | 296 719 | 286 070 | 376 983 | 305 600 | 1 259 384 | 1 289 652 | 1 759 367 | 1 850 839 | 1 770 061 | 1 923 502 |
| Long-term debt | 475 000 | 475 001 | 447 250 | 428 750 | 1 933 298 | 1 699 134 | 2 509 627 | 2 896 295 | 0 | 3 583 413 |
| Short-term debt | 226 496 | 276 325 | 347 798 | 428 683 | 394 905 | 569 934 | 462 321 | 532 314 | 3 431 530 | 774 979 |
| Total debt | 701 496 | 751 326 | 795 048 | 857 433 | 2 328 203 | 2 269 068 | 2 971 948 | 3 428 609 | 3 431 530 | 4 358 392 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20152024
Equity ratio
30.5%
This company
38.2%
Market median
+20% vs market
20152024
Return on equity
8.0%
This company
18.4%
Market median
-57% vs market
20152024
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20152024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20152024
Debt / equity
2.28×
This company
0.62×
Market median
-268% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
LP Chief Auditor | Chief Auditor | 2020 | — | — |
PS Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
FO Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nordstjernan Investment AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordstjernan AktiebolagNordstjernan Investment AB
Etac AB (this company)Etac SasEtac A/SEtac R82 GmbhEtac Polen Sp.Z.O.oKlaxon Mobility GmbhEtac Bil ASEtac Immedia A/SEtac LtdEtac R82 BvEtac BvEtac ASEtac GmbhR82 Holding ApsEtac Us Holding IncETAC GMBHKLAXON MOBILITY GMBHETAC IMMEDIA A/SR82 HOLDING APSETAC ASETAC A/SETAC POLEN SP.Z.O.OETAC US HOLDING INCETAC LTDETAC BVETAC SASBoard members of Etac AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Wirzberger | Chief Executive Officer | 0 companies |
| Leif Patrik Adolfsson | Chief Auditor | 0 companies |
| Pär Sigvard Åström | Chief Executive Officer | 0 companies |
| Fredrik Olof Dalborg | Chief Executive Officer | 0 companies |
| Mark-Philipp Lesjak | Board of Directors | 0 companies |
| Peter John Castagna | Board of Directors | 0 companies |
| Torben Helbo | Board of Directors | 0 companies |
| Nora Larssen | Chairman | 0 companies |
| Jesper Mailind | Board of Directors | 0 companies |
| Simon Georg Mattias Seretis | Board of Directors | 0 companies |
| Zlatko Rihter | Board of Directors | 0 companies |
| Paul Leeflang | Board of Directors | 0 companies |
| Daniel Lee Reuvers | Board of Directors | 0 companies |
| Tomas Gunnar Billing | Board of Directors | 0 companies |
| Anders Krister Stefan Johanson | Board of Directors | 0 companies |
| Philip Mark Croxford | Board of Directors | 0 companies |